Haemonetics (HAE) Financials

$120.02

up-down-arrow $-2.84 (-2.31%)

As on 19-Nov-2026 14:44EST

Market cap

info icon

$5,588 Mln

Revenue (TTM)

info icon

$1,382 Mln

P/E Ratio

info icon

54.3

P/B Ratio

info icon

6.1

Div. Yield

info icon

0 %

Income Statement ($ Mln)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Operating Revenue
1,382.46
1,334.03
1,360.82
1,309.06
1,168.66
993.20
Cost of Revenue
569.12
590.44
582.28
597.14
545.79
462.43
Gross Profit
813.33
743.59
778.55
711.92
622.87
530.77
Operating Expenses
559.75
502.19
556.73
547.03
466.84
450.02
Operating Profit (EBIT)
253.59
241.40
221.82
164.88
156.03
80.75
Other Income
--
--
--
--
-14.63
-17.12
Profit before Tax
142.01
128.03
212.07
151.87
141.40
63.63
Provision for Tax
38.10
30.72
44.39
34.31
26.00
20.25
Profit after Tax (Net Income)
103.91
97.31
167.68
117.56
115.40
43.38
Minority Interest
--
--
--
--
--
--
Consolidated Profit
44.74
--
167.68
117.56
115.40
43.38

Liabilities ($ Mln)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Shareholder's Funds
898.50
796.32
820.84
959.96
818.00
749.42
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
1,211.27
1,317.01
1,052.00
935.25
865.01
668.04
Current Liabilities
300.84
282.60
578.11
300.38
251.82
442.27
Total Liabilities
2,711.44
2,395.93
2,450.95
2,195.59
1,934.83
1,859.73

Assets ($ Mln)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Non-Current Assets
1,555.08
1,561.05
1,515.97
1,426.69
1,165.10
1,103.70
Current Assets
855.53
834.88
934.98
768.90
769.72
756.03
Total Assets
2,711.44
2,395.93
2,450.95
2,195.59
1,934.83
1,859.73
Total Debt*
1,123.76
1,224.58
1,224.79
807.79
765.89
780.79
Net Current Assets
554.69
552.28
356.86
468.52
517.91
313.77

Cashflow ($ Mln)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Cash From Operating Activities
--
293.22
181.73
181.75
273.06
172.26
Cash Flow from Investing Activities
--
-179.55
-161.90
-322.39
-143.79
-86.35
Cash from Financing Activities
--
-178.46
108.82
38.16
-100.36
-15.75
Net Cash Inflow / Outflow
--
--
--
--
28.91
70.17

Financials Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Adjusted EPS ($) info
2.24
2.11
3.39
2.29
2.25
0.84
Cash EPS ($) info
--
4.52
5.73
4.18
4.07
2.75
Adjusted Book Value ($) info
--
17.23
16.59
18.67
15.97
14.59
Dividend per Share ($) info
--
--
--
--
--
--
Cash Flow per Share ($) info
--
6.34
3.67
3.54
5.33
3.35
Free Cash Flow per Share ($) info
--
5.63
2.88
2.79
3.18
1.48

Profitability Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
ROCE (%) info
--
4.79
8.79
7.01
7.41
2.85
ROE (%) info
12.26
12.03
18.83
13.22
14.72
5.86
ROA (%) info
3.64
4.02
7.22
5.69
6.08
2.36
EBIT Margin (%) info
12.14
11.75
18.16
15.80
14.31
10.59
Net Margin (%) info
7.52
7.29
12.32
8.98
10.00
4.44
Cash Profit Margin (%) info
--
--
--
--
--
--

Growth Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Revenue Growth (%) info
4.11
-0.02
0.04
0.12
0.18
0.14
EBIT Growth (%) info
-35.54
-36.57
19.47
23.71
58.98
5.07
Net Profit Growth (%) info
-38.22
-41.97
42.64
1.87
166.05
-45.42
EPS Growth (%) info
-34.79
-0.38
0.48
0.01
1.67
-0.46
Book Value Growth (%) info
8.54
--
--
--
--
--

Valuation Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Price / Earnings info
54.30
26.77
18.75
37.32
36.73
74.85
Price / Book Value info
6.11
3.27
3.83
4.57
5.18
4.33
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
22.17
13.35
11.20
16.49
18.11
18.57
Close Price ($) info
105.30
56.36
63.55
85.35
82.75
63.22
High Price ($) info
110.45
87.32
97.97
95.26
91.39
119.88
Low Price ($) info
47.72
47.32
58.80
70.74
48.67
43.50
Market Cap ($ Cr) info
5,587.91
--
--
--
--
--

Solvency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debt to Equity info
1.24
1.54
1.49
0.84
0.94
1.04
Short term debt to equity ratio info
0.01
0.01
0.37
0.01
0.01
0.30
Current Ratio info
2.84
2.95
1.62
2.56
3.06
1.71
Quick Ratio info
1.83
1.87
0.99
1.50
2.03
1.05
Interest Coverage info
4.98
5.46
25.35
15.89
11.43
6.14

Operating Efficiency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debtors to sales (%) info
16.27
16.26
14.89
15.78
15.33
16.05
Asset Turnover info
0.48
0.55
0.59
0.63
0.62
0.54
Receivable days info
--
57.43
54.92
53.81
52.90
52.76
Inventory Days info
--
207.70
214.01
176.34
184.84
243.13
Payable days info
--
36.51
44.02
41.99
40.92
42.91
Cash Conversion Cycle info
--
228.62
224.91
188.16
196.82
252.98
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month